Gene · 6184
Papers1,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation of disulfidptosis and periodontitis: New insights and clinical significance. | Arch Oral Biol | 2024 | 38991331 | PubTator, text mining | PubMed |
| Ubiquitin recruiting chimera: more than just a PROTAC. | Biol Direct | 2024 | 38978100 | PubTator, text mining | PubMed |
| Multi-Omics Insights into Disulfidptosis-Related Genes Reveal RPN1 as a Therapeutic Target for Liver Cancer. | Biomolecules | 2024 | 38927080 | PubTator, text mining | PubMed |
| RPN1: a pan-cancer biomarker and disulfidptosis regulator. | Transl Cancer Res | 2024 | 38881923 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the disulfidptosis-related gene RPN1 and its potential biological function and prognostic significance in gliomas. | Heliyon | 2024 | 38845861 | PubTator, text mining | PubMed |
| VCP/p97 UFMylation stabilizes BECN1 and facilitates the initiation of autophagy. | Autophagy | 2024 | 38762759 | PubTator, text mining | PubMed |
| Transient interdomain interactions in free USP14 shape its conformational ensemble. | Protein Sci | 2024 | 38588275 | PubTator, text mining | PubMed |
| Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma. | Sci Rep | 2024 | 38531930 | PubTator, text mining | PubMed |
| Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer. | Cancer Cell Int | 2024 | 38528532 | PubTator, text mining | PubMed |
| Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data. | J Gastrointest Oncol | 2024 | 38482234 | PubTator, text mining | PubMed |
| Insight into telomere regulation: road to discovery and intervention in plasma drug-protein targets. | BMC Genomics | 2024 | 38431573 | PubTator, text mining | PubMed |
| Cell surface expression of Ribophorin I, an endoplasmic reticulum protein, over different cell types. | Int J Biol Macromol | 2024 | 38373565 | PubTator, text mining | PubMed |
| RPN1 promotes the proliferation and invasion of breast cancer cells by activating the PI3K/AKT/mTOR signaling pathway. | Discov Oncol | 2024 | 38302629 | PubTator, text mining | PubMed |
| Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer. | Nat Commun | 2024 | 38302471 | PubTator, text mining | PubMed |
| Intracellular Protein Adsorption Behavior and Biological Effects of Polystyrene Nanoplastics in THP-1 Cells. | Environ Sci Technol | 2024 | 38294362 | PubTator, text mining | PubMed |
| Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy. | Front Immunol | 2024 | 38292868 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma. | Medicine (Baltimore) | 2024 | 38277541 | PubTator, text mining | PubMed |
| The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications. | Int J Mol Sci | 2024 | 38256141 | PubTator, text mining | PubMed |
| Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer. | J Cancer | 2024 | 38230212 | PubTator, text mining | PubMed |
| Identification of sulfur metabolism-related gene signature in osteoarthritis and TM9SF2's sustenance effect on M2 macrophages' phagocytic activity. | J Orthop Surg Res | 2024 | 38218914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6184/papers?page=5